How ADA deficiency cured by gene therapy?

Explanation

Lymphocytes from the blood of the patient are grown in a culture outside the body. A functional ADA C-DNA (using a retroviral vector) is then introduced into these lymphocytes which are subsequently returned to the patients. These cells are immortal, so the patient requires periodic infusions of genetically modified lymphocytes.